Frazier Lifesciences Acquisition Corp

Frazier Lifesciences Acquisition Corp (Nasdaq: FLAC) is a blank-check company sponsored by Frazier Life Sciences, a venture capital firm with a long track record in the life sciences and biopharmaceutical sectors. The SPAC completed its initial public offering in February 2021, targeting acquisition opportunities across biotechnology, pharmaceuticals, and medical technology. FLAC filed an 8-K current report with the SEC on November 23, 2022, accession number 0001193125-22-292061, as the company continued its search for a merger target during an increasingly challenging environment for life sciences SPACs. Visit SpacDesk and sign up for full data, filings history, and real-time alerts on FLAC and hundreds of other active SPACs.